Moreover, patients with higher ANKRD49 showed lower OS (overall survival) rate and higher ANKRD49 expression in lung tissues may serve as an independent prognostic marker for NSCLC patients [10, 11]. This evidence concerns the gene ANKRD49 and non-small cell lung carcinoma.